LPTX
Leap Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.77
−3.15%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 9.62x
- PEG TTM
- —
- Price / book
- 0.21x
- Price / sales
- 152.61x
- Price / cash flow
- -0.36x
Enterprise value
- Enterprise value
- $17.9M
- EV / sales
- 85.64x
- EV / EBITDA
- -0.44x
- EV / EBIT
- -0.44x
- Market cap
- $31.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025